The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant buzz within the United Kingdom , prompting a notable shift in medication trends. Access these medications remains a complex landscape, with public healthcare system provision currently limited and specialist practices offering treatment at a premiu